top of page


Sacubitril/Valsartan showed a greater reduction of NT-proBNP in HFpEF patients: PARAMOUNT Study
Patients with documented left ventricular ejection fraction (LVEF) ≥ 50% are considered to have heart failure (HF) with preserved ejection fraction (HFpEF) (1). While HFpEF accounts for ~ 50% of patients with HF globally, it accounts for 15%–20% of patients with HF in India (2). HFpEF is characterized by increased left ventricular filling pressures and/or reduced cardiac output either at rest or on exertion. The body maintains the cardiac output by abnormally increasing the

Dr. Anuradha Mallya
Sep 9, 20253 min read
bottom of page